United States · FDA National Drug Code directory
Meprobamate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-974_9a6f46ed-9643-4911-9d5e-8175e836c881
- Product NDC
- 69097-974
- Form
- TABLET
- Composition / generic term
- Meprobamate
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210607
- Source listing expiry
- 20271231
Source-listed ingredients
- MEPROBAMATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (69097-974-07) · 69097-974-07
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →